Ventegra

Will new biosimilars hurt blockbuster autoimmune drug?
Will new biosimilars hurt blockbuster autoimmune drug?New biosimilars may harm the sales of this autoimmune blockbuster.
Is $485 million enough to end the opioid epidemic?
Is $485 million enough to end the opioid epidemic?The HHS is giving out greatly needed funds, but money alone may not be enough.